Newsroom | 25448 results

LONG BEACH, Calif.--(BUSINESS WIRE)--Aquarium of the Pacific president & CEO Dr. Peter Kareiva speaks about the benefits of nature and science during legislative hearing...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy heeft vandaag de publicatie aangekondigd van 's werelds eerste uitgebreide, zelfconsistente en robuuste fysicabasis, met conservatieve ontwerpmarges, voor een praktische testfusiecentrale. Deze fysicabasis wordt gepresenteerd in een serie van zeven door vakgenoten beoordeelde wetenschappelijke artikelen in een speciale uitgave van het prestigieuze Journal of Plasma Physics (JPP). Ze vormen de basis voor het eerste Infinity Two-stellarator-fusie...

KNOXVILLE, Tennessee--(BUSINESS WIRE)--Type One Energy oggi ha annunciato la pubblicazione delle prime basi di fisica al mondo complete, coerenti internamente e affidabili, con margini di progettazione prudenti, per la realizzazione di una centrale elettrica pilota basata sulla fusione. Queste basi di fisica vengono presentate in una serie di articoli scientifici sottoposti a peer review che compaiono in un’edizione speciale della prestigiosa rivista Plasma Physics (JPP) e servono da piattaform...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy a annoncé aujourd'hui la publication de la première base physique complète, cohérente et robuste au monde, avec des marges de conception conservatrices, pour une centrale pilote de fusion pratique. Cette base physique est présentée dans une série de sept articles scientifiques évalués par des pairs dans un numéro spécial du prestigieux Journal of Plasma Physics (JPP). Ils constituent la fondation du projet de la première centrale de fusion stel...

KNOXVILLE, Tennessee--(BUSINESS WIRE)--A Type One Energy anunciou hoje a publicação da primeira base física abrangente, autoconsistente e robusta do mundo, com margens de projeto conservadoras, para uma usina-piloto de energia de fusão prática. Essa base física é apresentada em uma série de sete artigos científicos revisados por pares em uma edição especial do prestigiado Journal of Plasma Physics (JPP). Esses artigos servem como base para o primeiro projeto de usina de energia de stellarator I...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy gab heute die Veröffentlichung der weltweit ersten umfassenden, in sich schlüssigen und robusten physikalischen Grundlage mit konservativen Entwurfsspannen für ein praktisches Fusions-Pilotkraftwerk bekannt. Diese physikalische Grundlage wird in einer Reihe von sieben von Experten begutachteten wissenschaftlichen Artikeln in einer Sonderausgabe des renommierten Journal of Plasma Physics (JPP) vorgestellt. Sie dienen als Grundlage für das erste...

EAST HANOVER, N.J.--(BUSINESS WIRE)--BioOx (www.bioox.us) announces today it has received certified listing from the Organic Materials Review Institute (OMRI) for organic production according to the USDA National Organic Program regulations for its agricultural growth supplement called BioOx Natural Media for Plants, also known as BioOx Grow (www.bioox.us/grow/). BioOx Grow is revolutionizing the farming process and enhances plant growth naturally for large and small scale agriculture, landscap...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Type One Energy announced today publication of the world’s first comprehensive, self-consistent, and robust physics basis, with conservative design margins, for a practical fusion pilot power plant. This physics basis is presented in a series of seven peer-reviewed scientific papers in a special issue of the prestigious Journal of Plasma Physics (JPP). They serve as the foundation for the company’s first Infinity Two stellarator fusion power plant project, whi...

LAS VEGAS & TAMPA, Fla.--(BUSINESS WIRE)--Certerra, a leading provider of technology-enabled testing, inspection, and certification services for critical infrastructure, today announced the acquisition of Tierra, Inc. (“Tierra”), a highly respected geotechnical and materials engineering firm with 27+ years of experience serving government agencies and private sector clients in Florida. The addition of Tierra strengthens Certerra’s presence in the Southeast and will provide both firms with addit...

雪梨--(BUSINESS WIRE)--(美國商業資訊)-- 國際知名的全方位受託研究機構 (CRO) 及科學諮詢公司Novotech發佈新的臨床前研究報告，深入探討小分子干擾RNA (siRNA) 治療領域的發展態勢。本報告透過深度洞察，旨在幫助生物技術與製藥企業運用RNA精準醫學技術，開拓新一代腫瘤學、代謝疾病及罕見遺傳疾病治療方案的新篇章。 挖掘siRNA在藥物研發中的潛力 siRNA療法透過精準沉默致病基因，為標靶藥物開發帶來了典範轉移。美國食品藥物管理局 (FDA) 核准了包括ONPATTRO™ (Patisiran) 和Inclisiran在內的多款siRNA藥物，該領域在遞送平台、穩定性及組織特異性標靶方面取得了快速進展。Novotech的報告概述當前的研發態勢與監管環境，並著重闡述siRNA技術如何擴展可成藥基因組，突破昔日的難成藥標靶問題。 主要重點： 臨床與監管情況：概述六種已獲FDA核准的siRNA療法，及其在心血管、肝臟及罕見遺傳疾病領域的適應症擴展情況。 siRNA遞送技術的進展：探討脂質奈米粒子 (LNPs)、GalNAc複合體和聚合物奈米粒子等創新突破，...